Technical Ventures RX Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Technical Ventures RX General Information

Description

Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1015 - 4 Street SouthWest
  • Suite 730
  • Calgary, Alberta T2R 1J4
  • Canada
Primary Industry
Special Purpose Acquisition Company (SPAC)
Acquirer
Corporate Office
  • 1015 - 4 Street SouthWest
  • Suite 730
  • Calgary, Alberta T2R 1J4
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Technical Ventures RX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Technical Ventures RX‘s full profile, request access.

Request a free trial

Technical Ventures RX Acquisitions (1)

Technical Ventures RX’s most recent deal was a Reverse Merger with Hemostemix. The deal was made on 10-Nov-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hemostemix 10-Nov-2014 Reverse Merger Biotechnology
To view Technical Ventures RX’s complete acquisitions history, request access »

Technical Ventures RX FAQs

  • When was Technical Ventures RX founded?

    Technical Ventures RX was founded in 2012.

  • Where is Technical Ventures RX headquartered?

    Technical Ventures RX is headquartered in Calgary, Canada.

  • What industry is Technical Ventures RX in?

    Technical Ventures RX’s primary industry is Special Purpose Acquisition Company (SPAC).

  • Is Technical Ventures RX a private or public company?

    Technical Ventures RX is a Private company.

  • What is Technical Ventures RX’s current revenue?

    The current revenue for Technical Ventures RX is .

  • How much funding has Technical Ventures RX raised over time?

    Technical Ventures RX has raised $303K.

  • When was Technical Ventures RX acquired?

    Technical Ventures RX was acquired on 12-Nov-2014.

  • Who acquired Technical Ventures RX?

    Technical Ventures RX was acquired by Hemostemix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process